F, B., SG, H., L, L., C, D., RR, G., E, S., . . . Jr, G. M. (2021). Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy. PLoS pathogens, 17(7), e1009278. https://doi.org/10.1371/journal.ppat.1009278
Chicago Style (17th ed.) CitationF, Barrenäs, et al. "Interleukin-15 Response Signature Predicts RhCMV/SIV Vaccine Efficacy." PLoS Pathogens 17, no. 7 (2021): e1009278. https://doi.org/10.1371/journal.ppat.1009278.
MLA (9th ed.) CitationF, Barrenäs, et al. "Interleukin-15 Response Signature Predicts RhCMV/SIV Vaccine Efficacy." PLoS Pathogens, vol. 17, no. 7, 2021, p. e1009278, https://doi.org/10.1371/journal.ppat.1009278.
Warning: These citations may not always be 100% accurate.